These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 15890798)

  • 1. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.
    Touyz RM
    Exp Physiol; 2005 Jul; 90(4):449-55. PubMed ID: 15890798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox signaling in hypertension.
    Paravicini TM; Touyz RM
    Cardiovasc Res; 2006 Jul; 71(2):247-58. PubMed ID: 16765337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II and the vascular phenotype in hypertension.
    Savoia C; Burger D; Nishigaki N; Montezano A; Touyz RM
    Expert Rev Mol Med; 2011 Mar; 13():e11. PubMed ID: 21450123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension.
    Touyz RM; Tabet F; Schiffrin EL
    Clin Exp Pharmacol Physiol; 2003 Nov; 30(11):860-6. PubMed ID: 14678251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
    Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II and vascular injury.
    Montezano AC; Nguyen Dinh Cat A; Rios FJ; Touyz RM
    Curr Hypertens Rep; 2014 Jun; 16(6):431. PubMed ID: 24760441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.
    De Ciuceis C; Amiri F; Brassard P; Endemann DH; Touyz RM; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2106-13. PubMed ID: 16100037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
    Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II and vascular inflammation.
    Cheng ZJ; Vapaatalo H; Mervaala E
    Med Sci Monit; 2005 Jun; 11(6):RA194-205. PubMed ID: 15917731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of angiotensin II in regulating vascular structural and functional changes in hypertension.
    Touyz RM
    Curr Hypertens Rep; 2003 Apr; 5(2):155-64. PubMed ID: 12642016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
    Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothetical mechanism of sodium pump regulation by estradiol under primary hypertension.
    Sudar E; Velebit J; Gluvic Z; Zakula Z; Lazic E; Vuksanovic-Topic L; Putnikovic B; Neskovic A; Isenovic ER
    J Theor Biol; 2008 Apr; 251(4):584-92. PubMed ID: 18304583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased migration of vascular adventitial fibroblasts from spontaneously hypertensive rats.
    Li L; Zhu DL; Shen WL; Gao PJ
    Hypertens Res; 2006 Feb; 29(2):95-103. PubMed ID: 16755143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
    Schulman IH; Zhou MS; Raij L
    J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.
    Kim S; Iwao H
    Pharmacol Rev; 2000 Mar; 52(1):11-34. PubMed ID: 10699153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation.
    Zhang GX; Lu XM; Kimura S; Nishiyama A
    Cardiovasc Res; 2007 Nov; 76(2):204-12. PubMed ID: 17698051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease.
    Touyz RM
    Braz J Med Biol Res; 2004 Aug; 37(8):1263-73. PubMed ID: 15273829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-stimulated NADH/NAD+ redox state increases NAD(P)H oxidase activity in cultured rat vascular smooth muscle cells.
    Yang M; Kahn AM
    Am J Hypertens; 2006 Jun; 19(6):587-92. PubMed ID: 16733230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.
    Touyz RM; Schiffrin EL
    Pharmacol Rev; 2000 Dec; 52(4):639-72. PubMed ID: 11121512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral vascular effects of angiotensin II: new insights from genetic models.
    Faraci FM; Lamping KG; Modrick ML; Ryan MJ; Sigmund CD; Didion SP
    J Cereb Blood Flow Metab; 2006 Apr; 26(4):449-55. PubMed ID: 16094317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.